STAT3 Dominant Negative Disease: NIH Cohort

被引：0

作者：

Freeman, Alexandra ^{[1
]}

Urban, Amanda ^{[2
]}

Martin, Iris ^{[3
]}

An, Zixiao ^{[4
]}

Ali, Sania ^{[5
]}

Lerman, Jacob ^{[6
]}

Lafeer, Christine ^{[7
]}

Roy, Susan ^{[8
]}

Ulrick, Jean ^{[7
]}

Davis, Joie ^{[3
]}

Bergerson, Jenna ^{[7
]}

Holland, Steven ^{[9
]}

Heimall, Jennifer ^{[10
]}

机构：

[1] NIAID, Lab Clin Immunol & Microbiol, NIH, Bethesda, MD USA

[2] Frederick Natl Lab Canc Res, Clin Res Directorate, Frederick, MD USA

[3] NIAID, NIH, Bethesda, MD USA

[4] NIAID, LCIM, Bethesda, MD USA

[5] Hackensack Meridian Sch Med, Hackensack, NJ USA

[6] NIAID, Lab Clin Immunol & Microbiol, NIH, Bethesda, MD USA

[7] NIAID, LCIM, NIH, Bethesda, MD USA

[8] Ctr Clin, NIH, Bethesda, MD USA

[9] NIAID, NIH, Div Intramural Res, Bethesda, MD USA

[10] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

来源：

CLINICAL IMMUNOLOGY | 2024年 / 262卷

关键词：

Hyper IgE syndrome; STAT3; Natural history;

D O I：

10.1016/j.clim.2024.110025

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：3

共 50 条

[21] AUTOSOMAL DOMINANT STAT3 MUTATION IN A HUNGARIAN HIES PATIENT
Csuerke, Ildiko
Kassay, Anett
Soltesz, Beata
Dicso, Ferenc
Marodi, Laszlo
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 715 - 715
[22] Negative regulators of STAT3 signaling pathway in cancers
Wu, Moli
Song, Danyang
Li, Hui
Yang, Yang
Ma, Xiaodong
Deng, Sa
Ren, Changle
Shu, Xiaohong
CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4957 - 4969
[23] Serine Phosphorylation and Negative Regulation of Stat3 by JNK
Signal Transduction Laboratory, Inst. of Molecular and Cell Biology, National University of Singapore, Singapore 117609, Singapore
不详
J Biol Chem, 43 (31055-31061):
[24] Serine phosphorylation and negative regulation of Stat3 by JNK
Lim, CP
Cao, XM
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) : 31055 - 31061
[25] Hyper-IgE associated mutant STAT3 proteins exert a dominant negative effect on STAT3 transcriptional activity via different mechanisms depending on the domain of the protein affected
Barboza, J. A.
Anover-Sombke, S.
Rylaarsdam, D.
Renner, E. D.
Laflam, T.
Ocheltree, E.
Ochs, H. D.
Torgerson, T. R.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 19 - 19
[26] Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations
Blanco Lobo, Pilar
Guisado-Hernandez, Paloma
Villaoslada, Isabel
de Felipe, Beatriz
Carreras, Carmen
Rodriguez, Hector
Carazo-Gallego, Begona
Mendez-Echevarria, Ana
Manuel Lucena, Jose
Ortiz Aljaro, Pilar
Jose Castro, Maria
Francisco Noguera-Ucles, Jose
Milner, Joshua D.
McCann, Katelyn
Zimmerman, Ofer
Freeman, Alexandra F.
Lionakis, Michail S.
Holland, Steven M.
Neth, Olaf
Olbrich, Peter
JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (06) : 1193 - 1204
[27] Targeting the STAT3 pathway with STAT3 degraders
Wang, Zhijie
Liao, Xiaotong
He, Haiqi
Guo, Xia
Chen, Jianjun
TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (09) : 811 - 823
[28] Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations
Pilar Blanco Lobo
Paloma Guisado-Hernández
Isabel Villaoslada
Beatriz de Felipe
Carmen Carreras
Hector Rodriguez
Begoña Carazo-Gallego
Ana Méndez-Echevarria
José Manuel Lucena
Pilar Ortiz Aljaro
María José Castro
José Francisco Noguera-Uclés
Joshua D. Milner
Katelyn McCann
Ofer Zimmerman
Alexandra F. Freeman
Michail S. Lionakis
Steven M. Holland
Olaf Neth
Peter Olbrich
Journal of Clinical Immunology, 2022, 42 : 1193 - 1204
[29] A challenging differential diagnosis in a patient with autosomal dominant STAT3 deficiency
Bravo-Queipo-de-Llano, Blanca
Bonet, Daniel
del Rosal, Teresa
Camara, Carmen
de Valbuena, Marta Ruiz
Perez, Ana
Grasa, Carlos D.
Mendez-Echevarria, Ana
PEDIATRIC PULMONOLOGY, 2023, 58 (02) : 585 - 591
[30] Targeting STAT3 signaling in kidney disease
Pace, Jesse
Paladugu, Praharshasai
Das, Bhaskar
He, John C.
Mallipattu, Sandeep K.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 316 (06) : F1151 - F1161

← 1 2 3 4 5 →